|
|||||
|
|
|
|
|
|
| |||||
 |
 |
||||||
|
 |
 |
 |
 |
 |
|
 |
|
CANTEST Increases Bioanalytical Capacity - Sciex API 4000SPECIAL ANNOUNCEMENT June 30, 2004 Burnaby, B.C. - Leading Canadian Life Sciences Laboratory CANTEST Ltd. invests in an additional Sciex API 4000 LC/MS/MS instrument. The acquisition of the organization's third API 4000, announced today by CANTEST president Don M. Enns, significantly improves capacity within the company's bioanalytical division (formerly known as ABR). The company now features in excess of $10M in state-of-the art analytical instrumentation including a total of five production LC/MS/MS units at its Life Sciences Centre in Burnaby, BC. Dr. Adrien Musuku, Laboratory Director for CANTEST's bioanalytical division, was highly supportive of the company's decision to standardize on API 4000 technology: “This particular instrument is the most sensitive LC/MS/MS solution available. In addition, these systems are particularly robust; allowing us to reduce downtime, increase throughput and deliver an extremely high quality service in a tight time frame.” Mr. Enns states: “This purchase is a direct response to customers and sponsors who have indicated a desire to place more studies with CANTEST...By acquiring a third API 4000, CANTEST is well positioned to take on larger studies while maintaining an internal commitment to ongoing research and method development activities.” CANTEST is an employee-owned and operated full-service testing company, offering professional method development and analysis for over 35 years. The company has Canadian offices in Burnaby, Richmond, Kelowna, Winnipeg and Victoria, and is the flagship of the CANAM Laboratories Group which operates facilities in Canada, the United States and Southeast Asia. CANTEST's bioanalytical division (formerly known as ABR Axelson BioPharma Research) specializes in contract research, method development and high-throughput sample analysis in support of a broad range of clinical and drug development projects. Their team of highly experienced scientists utilize the latest in LC/MS/MS technology to provide innovative, cost-effective solutions under strict a GLP compliant quality system. For further information regarding this release, or to learn more about CANTEST's analytical and support services, please contact: Catherine McGuinness Steve Timuss Printable PDF Version |
|
||||||||||
|
|
|
|||||||||||
|
|
|
|
|
|
||||||||
 |
 |
 |
 |
 |
 |